Skip to main content
KYMR logo

KYMR · Kymera Therapeutics, Inc.

Track KYMR — free
$117.39 +0.11 (+0.09%) At close · Sep 4
Market Cap
$9.68B
Shares
83.15M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 46 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1815442 CUSIP 501575104 13F (30d) 222 filings 215 filers Visit website Investor relations